Device Trial Radar · NCT06922084
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
320
Planned (sponsor's estimate)
Start
Mar 17, 2025
Primary completion
Apr 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- Berkeley Eye CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Sengi
- First posted
- Apr 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Prospective, randomized, multicenter, multi-arm, subject and vision-assessor-masked, two stage study with Stage 1 as a three-arm initial enrollment period, followed by Stage 2 as a head-to-head study refined based on the Stage 1 data.
Conditions
- Cataract
Interventions
Clareon PanOptixDevice
Bilateral Clareon PanOptix IOL implantation
Clareon PanOptix PRODrug
Bilateral Clareon PanOptix PRO IOL implantation
Mix-and-Match PanOptix/VivityDrug
Clareon PanOptix Pro in the non-dominant eye and Clareon Vivity in the dominant eye
Primary outcomes
What the sponsor says the trial is designed to measure.
- Binocular photopic CDVA (corrected distance visual acuity)Time frame: 3 months postoperatively
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Shafer Vision Institute
Plymouth Meeting, Pennsylvania · Recruiting
Berkeley Eye Center
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.